A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...

The change will expand access to the diabetes and weight-loss drugs. But it will also complicate the future of compounded ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its ...

After nearly two years, federal regulators announced the shortage of the active ingredient in Mounjaro and Zepbound has been ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Mounjaro, the brand name for tirzepatide, is a drug that treats type 2 diabetes by lowering blood sugar levels. According to ...

This lengthy study with the drug Mounjaro seems to point to even better success than they’d hoped. Eli Lilly, the mind behind ...

The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...